《大行報告》高盛上調中國鐵塔(00788.HK)目標價至1.1元 評級「中性」
高盛發表報告指,中國鐵塔(00788.HK)上半年收入低於該行預期2%,惟純利高於預期6%,主要是營運支出下降所帶動,而其營運現金流按年跌63%,錄現金流赤字達137億元人民幣,因應收賬款暫時增加所致,故被視為負面影響。
至於前景及指引方面,管理層認為透過持續成本或費用控制,以及智能塔、能源業務等發展潛力,公司前景保持穩健。該行認為,公司執行表現良好,抵銷了降價的影響,對其前景更具信心,將公司2023年至2025年純利預測上調3%至10%,目標價由1.04元上調至1.1元,維持「中性」評級。(ca/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.